1-9 of 9
Palka Anand
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2b Study of Selinexor in Combination with Pomalidomide in Patients with Pomalidomide-Refractory Multiple Myeloma

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly R. Doucette, Rena Feinman, Xue Geng, Jaeil Ahn, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Alexandra Della Pia, Bianca DeAgresta, Lisa Biamonte, Martha Campanaro, Trina McClendon, Samanta BaboolallAracena, Adolfo Aleman, Ella Rutanen, Marie Layton, Genevieve Breeze, Aimee Chappell, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2024) 144 (Supplement 1): 7070.
https://doi.org/10.1182/blood-2024-208473
Published: 2024
Journal Articles

A Phase 1/2 Study of Carfilzomib, Iberdomide and Dexamethasone (KID) in Patients with Newly Diagnosed Transplant-Eligible Multiple Myeloma

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly Doucette, Rena Feinman, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Lisa Biamonte, Martha Campanaro, Trina McClendon, Chandani Limbad, Samanta BaboolallAracena, Adolfo Aleman, Rashmi Unawane, Elizabeth Pendergrass, Marie Layton, Genevieve Breeze, Aimee Chappell, Alexandra Della Pia, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2023) 142 (Supplement 1): 2022.
https://doi.org/10.1182/blood-2023-189907
Published: 2023
Journal Articles

A Phase 2b Study of Selinexor in Combination with Carfilzomib, Daratumumab, or Pomalidomide in Patients with Multiple Myeloma Relapsing on Current Therapy

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly Doucette, Rena Feinman, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Lisa Biamonte, Martha Campanaro, Trina McClendon, Chandani Limbad, Samanta BaboolallAracena, Adolfo Aleman, Rashmi Unawane, Elizabeth Pendergrass, Marie Layton, Genevieve Breeze, Aimee Chappell, Alexandra Della Pia, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6714.
https://doi.org/10.1182/blood-2023-187011
Published: 2023
Journal Articles

Two Year Update of Phase II Trial of Pembrolizumab, Lenalidomide and Dexamethasone As Post -Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Meena Bansal, DO, David S. Siegel, Jaeil Ahn, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Andrew L. Pecora, MD, Elli Gourna Paleoudis, PhD, Scott D. Rowley, MD, Michele L. Donato, MD, Robert Korngold, PhD, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1911.
https://doi.org/10.1182/blood-2019-125155
Published: 2019
Journal Articles

A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone As Post Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Noa Biran, MD, Tracy Andrews, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Joshua Zenreich, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Robert Korngold, PhD, David Siegel, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1831.
https://doi.org/10.1182/blood.V130.Suppl_1.1831.1831
Published: 2017
Journal Articles

Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma

Noa Biran, MD, David H. Vesole, MD PhD, Shijia Zhang, MD PhD, Joshua R. Richter, MD, Yen-Hong Kuo, PhD, Linda Schmidt, RN BSN MSN OCN CNL, Laura McBride, RN, BSN, OCN, CCRP, Palka Anand, BSN, Kristin Ivanovski, RN, Amy Pierre, RN, MSN, APN, Susan Kumka, RN, MSN, APN, Carmela Cuccurullo, RN, MSN, APN, David S. Siegel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5685.
https://doi.org/10.1182/blood.V128.22.5685.5685
Published: 2016
Journal Articles

Vorinostat in Combination with Lenalidomide (L) and Dexamethasone (d) in Multiple Myeloma Patients Refractory to Previous Lenalidomide-Containing Regimens: Results of a Phase IIb Trial

Larysa Sanchez, MD, Yucai Wang, MD PhD, Laura McBride, RN, BSN, OCN, CCRP, Elizabeth Bilotti, MSN, David H. Vesole, MD, Joshua Richter, MD, Noa Biran, MD, Palka Anand, Kristin Ivanovski, Ann McNeill, ANP, David Siegel, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4264.
https://doi.org/10.1182/blood.V126.23.4264.4264
Published: 2015
Journal Articles

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Clinical Trials & Observations
Paul G. Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob Laubach, Daniel Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Nora Loughney, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Sandra Wear, Gail Larkins, Min Chen, Mohamad H. Zaki, Christian Jacques, Kenneth C. Anderson
Journal: Blood
Blood (2013) 121 (11): 1961–1967.
https://doi.org/10.1182/blood-2012-08-450742
Published: 2013
Journal Articles

Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma,

Joshua R. Richter, MD, Elizabeth Bilotti, MSN, RN, Laura McBride, Linda Schmidt, Zhijie Gao, MD, Madiha Tufail, MD, Palka Anand, Ann McNeill, Urszula Bednarz, Thorsten Graef, MD, PhD, David H. Vesole, MD, PhD, David S. Siegel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3986.
https://doi.org/10.1182/blood.V118.21.3986.3986
Published: 2011